Near-Patient Molecular Solution Market Revenue 2024 to 2034
Near-Patient Molecular Solution Market Revenue 2024 to 2034
The Near-Patient Molecular Solution Market will grow from USD 12.00 Bn in 2024 to USD 38.76 Bn by 2034, advancing at a CAGR of 12.4%.
Report ID: 10295
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 12.00 Bn
Forecast Year,
USD USD 38.76 Bn
CAGR, 2025 -
12.4%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Near-Patient Molecular Solution Market Size Analysis
Near-Patient Molecular Solution Market Size By Technology 2024 to 2034 (USD )
| Technology | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PCR POCT | 5.28 | 5.95 | 6.67 | 7.46 | 8.39 | 9.42 | 10.50 | 11.82 | 13.28 | 14.95 | 16.86 |
| Isothermal (LAMP/TMA) | 3.12 | 3.51 | 3.95 | 4.46 | 5.03 | 5.66 | 6.38 | 7.14 | 8.04 | 9.01 | 10.13 |
| Microfluidic Cartridge | 2.40 | 2.69 | 3.02 | 3.43 | 3.86 | 4.33 | 4.93 | 5.58 | 6.27 | 7.05 | 7.89 |
| CRISPR-based | 0.72 | 0.81 | 0.92 | 1.03 | 1.15 | 1.29 | 1.46 | 1.64 | 1.85 | 2.08 | 2.32 |
| Others | 0.48 | 0.54 | 0.60 | 0.68 | 0.76 | 0.86 | 0.97 | 1.09 | 1.23 | 1.38 | 1.56 |
Near-Patient Molecular Solution Market Size By Sample Type 2024 to 2034 (USD )
| Sample Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory Swab | 4.56 | 5.13 | 5.75 | 6.45 | 7.28 | 8.23 | 9.25 | 10.39 | 11.61 | 13.03 | 14.59 |
| Blood/Plasma | 3.12 | 3.51 | 3.95 | 4.44 | 4.97 | 5.58 | 6.30 | 7.07 | 7.99 | 8.98 | 10.18 |
| Urine | 1.68 | 1.89 | 2.14 | 2.40 | 2.69 | 3.01 | 3.38 | 3.80 | 4.31 | 4.84 | 5.46 |
| Stool | 0.96 | 1.08 | 1.21 | 1.36 | 1.54 | 1.73 | 1.94 | 2.19 | 2.45 | 2.77 | 3.10 |
| Others | 1.68 | 1.89 | 2.13 | 2.40 | 2.70 | 3.02 | 3.37 | 3.81 | 4.30 | 4.85 | 5.43 |
Near-Patient Molecular Solution Market Size By Care Setting 2024 to 2034 (USD )
| Care Setting | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ED/Urgent Care | 3.12 | 3.52 | 3.95 | 4.46 | 5.00 | 5.62 | 6.34 | 7.11 | 7.95 | 8.89 | 9.93 |
| Physician Office | 2.64 | 2.96 | 3.32 | 3.73 | 4.17 | 4.69 | 5.29 | 5.98 | 6.75 | 7.57 | 8.55 |
| Pharmacy | 2.16 | 2.42 | 2.72 | 3.03 | 3.40 | 3.82 | 4.30 | 4.82 | 5.40 | 6.09 | 6.86 |
| Home/At-home | 2.40 | 2.71 | 3.06 | 3.45 | 3.91 | 4.40 | 4.91 | 5.53 | 6.24 | 7.05 | 7.95 |
| Others | 1.68 | 1.90 | 2.13 | 2.40 | 2.71 | 3.03 | 3.40 | 3.82 | 4.32 | 4.87 | 5.46 |
Near-Patient Molecular Solution Market Size By End-User 2024 to 2034 (USD )
| End-User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 4.32 | 4.82 | 5.44 | 6.08 | 6.83 | 7.65 | 8.58 | 9.68 | 10.88 | 12.28 | 13.85 |
| Clinics | 3.36 | 3.79 | 4.25 | 4.79 | 5.40 | 6.10 | 6.87 | 7.70 | 8.67 | 9.74 | 10.93 |
| Diagnostic Labs | 2.40 | 2.73 | 3.07 | 3.45 | 3.86 | 4.33 | 4.88 | 5.48 | 6.16 | 6.87 | 7.72 |
| Retail/Other | 1.92 | 2.15 | 2.42 | 2.74 | 3.09 | 3.49 | 3.93 | 4.41 | 4.95 | 5.58 | 6.25 |
Near-Patient Molecular Solution Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 5.04 | 5.65 | 6.35 | 7.14 | 8.00 | 8.97 | 10.10 | 11.39 | 12.85 | 14.46 | 16.22 |
| Europe | 3.36 | 3.79 | 4.25 | 4.78 | 5.41 | 6.10 | 6.85 | 7.66 | 8.61 | 9.67 | 10.97 |
| Asia Pacific | 2.88 | 3.24 | 3.66 | 4.11 | 4.62 | 5.20 | 5.85 | 6.57 | 7.35 | 8.26 | 9.23 |
| Latin America | 0.36 | 0.40 | 0.45 | 0.51 | 0.57 | 0.64 | 0.71 | 0.81 | 0.91 | 1.02 | 1.14 |
| Middle East & Africa | 0.36 | 0.41 | 0.46 | 0.52 | 0.59 | 0.66 | 0.74 | 0.84 | 0.94 | 1.07 | 1.20 |
Near-Patient Molecular Solution Market
Near-Patient Molecular Solution Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
